Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)
<p>Abstract</p> <p>Background</p> <p><it>TP53 </it>is an attractive candidate for modifying age of onset (AO) in Huntington disease (HD): The amino-terminus of the mutated huntingtin (htt) exon 1 translation product has functional properties which may affect...
Main Authors: | Andrich Jürgen, Saft Carsten, Kraus Peter H, Arning Larissa, Epplen Jörg T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-10-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/6/35 |
Similar Items
-
Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease
by: Saft Carsten, et al.
Published: (2004-03-01) -
No association between polymorphisms in the <it>BDNF </it>gene and age at onset in Huntington disease
by: Kraus Peter H, et al.
Published: (2006-11-01) -
Error processing in Huntington's disease.
by: Christian Beste, et al.
Published: (2006-01-01) -
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.
by: Gisa Ellrichmann, et al.
Published: (2011-01-01) -
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease
by: Haghikia Aiden, et al.
Published: (2011-05-01)